期刊文献+

家庭雾化治疗儿童喘息性疾病的疗效及对患儿用药依从性的影响分析 被引量:1

Efficacy of family nebulization therapy in children with asthmatic diseases and its influence on medication compliance
在线阅读 下载PDF
导出
摘要 目的分析家庭雾化治疗儿童喘息性疾病的疗效及对患儿用药依从性的影响。方法选取121例喘息性疾病患儿作为研究对象,给予患儿家庭雾化治疗及护理,观察患儿临床症状缓解时间、治疗效果、用药依从性及不良反应发生情况。结果患儿治疗期间不良反应发生率为1.65%;哮鸣音消失时间为(4.82±1.18)d、活动受限好转时间为(3.48±0.58)d、喘息好转时间为(5.16±1.01)d、咳嗽缓解时间为(4.43±0.96)d;临床治疗总有效率为97.52%。患儿用药依从率为98.35%。结论给予喘息性疾病患儿家庭雾化治疗具有确切的治疗效果,可有效改善患儿临床症状,具有较高的有效性、安全性和可行性,治疗依从性好,在临床实践中值得广泛推广和应用。 Objective To analyze the efficacy of family nebulization therapy in children with asthmatic diseases and its influence on medication compliance. Methods There were 121 children with asthmatic diseases as study subjects, all received family nebulization and nursing. The remission time of clinical symptoms, therapeutic effect, medication compliance and occurrence of adverse reactions of children were observed. Results During the treatment, the incidence of adverse reactions was 1.65%;the disappearance time of wheezing was(4.82±1.18) d, the improvement time of activity restriction was(3.48±0.58) d, the improvement time of wheezing was(5.16±1.01) d, and the remission time of cough was(4.43±0.96) d;the total effective rate of clinical treatment was 97.52%, and medication compliance was 98.35%. Conclusion Family atomization therapy has a definite therapeutic effect for children with asthmatic disease, which can effectively improve the clinical symptoms of children, and has high effectiveness, safety and feasibility, and good medication compliance. It is worthy of extensive promotion and application in clinical practice.
作者 刘广文 兰涛 叶黄建 LIU Guang-wen;LAN Tao;YE Huang-jian(Mindong Hospital Affiliated to Fujian Medical University,Ningde 355000,China)
出处 《中国实用医药》 2021年第10期36-38,共3页 China Practical Medicine
关键词 家庭雾化治疗 儿童喘息性疾病 用药依从性 Family nebulization therapy Asthmatic diseases in children Medication compliance
  • 相关文献

参考文献14

二级参考文献96

  • 1Wong GW, Kwon N, Hong JG, et al. Pediatric asthma control in Asia: phase 2 of the Asthma Insights and Reality in Asia-Pacific(AIRIAP 2) survey [J]. Allergy, 2013, 68(4) : 524-530.
  • 2Chipps BE, Schnepp CM, Briscoe M. Budesonide inhalation suspension reduces the need for emergency intervention in pediatric asthma: a named-patient case series [J]. J Asthma, 2003, 40(8): 895-900.
  • 3Nuhoglu Y, Atas E, Nuhoglu C, et al. Acute effect of nebulized budesonide in asthmatic children [J]. J Investig Allergol Clin Immunol, 2005, 15(3): 197-200.
  • 4Castro-Rodriguez GA, Rodrigo GJ. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis [J]. Arch Dis Child, 2010, 95(5): 365-370.
  • 5Szefler S J, Carlsson LG, Uryniak T, et al. Budesonide inhalation suspension versus montelthkast in children aged 2 to 4 years with mild persistent asthma [J]. J Allergy Clin lmmunol Pract, 2013, 1(1): 58-64.
  • 6The Nebulizer Project Group of the British Thoracic Society Standards of Care Committee. Current best practice for nebuliser treatment[J].Thorax, 1997, 52(Supp12): S1-106.
  • 7O'Donohue WJ Jr. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group [J]. Chest, 1996, 109(3): 814-820.
  • 8Boe J, Dennis JH, O'Driscoll BR, et al. European Respiratory Society Guidelines on the use of nebulizers [J]. Eur Respir J, 2001, 18(1): 228-242.
  • 9Zeiger RS, Mauger D, Bacharier LB, et aL Daily or intermittent budesonide in preschool children with recurrent wheezing [J]. N Engl J Med, 2011, 365(21): 1990-2001.
  • 10Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma [J]. J Allergy C lin Immunol, 1999, 104(4 Pt 2): 200-209.

共引文献2939

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部